Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Falanga, Annarita ^a   Tarallo, Rossella ^b   Carberry, Thomas ^b   Galdiero, Massimiliano ^c   Weck, Marcus ^b   Galdiero, Stefania ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NEW YORK UNIVERSITY   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; GH625; LIPOSOME; UNCLASSIFIED DRUG; GH625 PEPTIDE, HERPES SIMPLEX VIRUS TYPE I; PEPTIDE; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

ARTICLE; BILAYER MEMBRANE; BINDING AFFINITY; CONTROLLED STUDY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; INTERNALIZATION; ISOTHERMAL TITRATION CALORIMETRY; MEMBRANE PERMEABILITY; SURFACE PLASMON RESONANCE;

DENDRIMERS; LIPOSOMES; PEPTIDES; PROTEIN BINDING; VIRAL ENVELOPE PROTEINS;

EID: 84912567708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112128     Document Type: Article

References (71)

1. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23: 3-25.
2. Torchilin VP (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annual Review of Biomedical Engineering. Palo Alto: Annual Reviews. pp. 343-375.
3. Accardo A, Tesauro D, Morelli G (2013) Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors. Polym J 45: 481-493.
4. Sanna V, Pala N, Sechi M (2014) Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine 9: 467-483.
5. Newkome GR, Moorefield CN, Vögtle F (2001) Dendrimers and Dendrons: Concepts, Synthesis, Applications. Weinheim: Wiley-VCH.
6. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nature Biotech 23: 1517-1526.
7. Gillies ER, Frechet JMJ (2005) Dendrimers and dendritic polymers in drug delivery. Drug Discovery Today 10: 35-43.
8. Pearson RM, Sunoqrot S, Hsu HJ, Bae JW, Hong S (2012) Dendritic nanoparticles: the next generation of nanocarriers? Therapeutic delivery 3: 941-959.
9. Seib FP, Jones AT, Duncan R (2007) Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Control Release 117: 291-300.
10. Saovapakhiran A, D'Emanuele A, Attwood D, Penny J (2009) Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization. Bioconjug Chem 20: 693-701.
11. Galdiero S, Vitiello M, Falanga A, Cantisani M, Incoronato N, et al. (2012) Intracellular delivery: exploiting viral membranotropic peptides. Curr Drug Metab 13: 93-104.
12. Falanga A, Cantisani M, Pedone C, Galdiero S (2009) Membrane fusion and fission: enveloped viruses. Protein Pept Lett 16: 751-759.
13. Falanga A, Tarallo R, Vitiello G, Vitiello M, Perillo E, et al. (2012) Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex type I virus. PLoS One 7: e32186.
14. Tarallo R, Accardo A, Falanga A, Guarnieri D, Vitiello G, et al. (2011) Clickable Functionalization of Liposomes with gH625 Peptide from Herpes Simplex Virus type I for Intracellular Delivery. Chem Eur J 17: 12659-12668.
15. Falanga A, Vitiello M, Cantisani M, Tarallo R, Guarnieri D, et al. (2011) A peptide derived from HSV1gH: membrane translocation and applications to delivery of QDs. Nanomedicine 7: 925-934.
16. Galdiero S, Falanga A, Vitiello M, Browne H, Pedone C, et al. (2005) Fusogenic Domains in Herpes Simplex Virus Type I Glycoprotein H. J Biol Chem 280: 28632-28643.
17. Galdiero S, Falanga A, Vitiello M, Raiola L, Fattorusso R, et al. (2008) Analysis of a Membrane Interacting Region of Herpes Simplex Virus Type I Glycoprotein H. J Biol Chem 283: 29993-30009.
18. Galdiero S, Falanga A, Vitiello M, Raiola L, Russo L, et al. (2010) The Presence of a Single N-terminal Histidine Residue Enhances the Fusogenic Properties of a Membranotropic Peptide Derived from Herpes Simplex Virus type I Glycoprotein H. J Biol Chem 285: 17123-17136.
19. Galdiero S, Falanga A, Vitiello G, Vitiello M, Pedone C, et al. (2010) Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process. Biochim Biophys Acta 1798: 579-591.
20. Galdiero S, Russo L, Falanga A, Cantisani M, Vitiello M, et al. (2012) Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system. Biochemistry 51: 3121-3128.
21. Mae M, Langel U (2006) Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 6: 509-514.
22. Carberry TP, Tarallo R, Falanga A, Finamore E, Galdiero M, et al. (2012) Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery. Chemistry 18: 13678-13685.
23. Tarallo R, Carberry TP, Falanga A, Vitiello M, Galdiero S, et al. (2013) Dendrimers functionalized with membrane-interacting peptides for viral inhibition. Int J Nanomedicine 8: 521-534.
24. Roberts JC, Bhalgat MK, Zera RT (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. Biomed Mater Res 30: 53-65.
25. Ornelas C, Pennell R, Liebes LF, Weck M (2011) Construction of a Well-Defined Multifunctional Dendrimer for Theranostics. Org Lett 13: 967-979.
26. Ruzza P, Biondi B, Marchiani A, Antolini N, Calderan A (2010) Cell-Penetrating Peptides: A Comparative Study on Lipid Affinity and Cargo Delivery Properties. Pharmaceuticals 3: 1045-1062.
27. Castile JD, Taylor KMG, Buckton G (1999) A high sensitivity differential scanning calorimetry study of the interaction between poloxamers and dimyristoylphosphatidylcholine and dipalmitoylphosphatidylcholine liposomes. International Journal of Pharmaceutics 182: 101-110.
28. Purohit G, Sakthivel T, Florence AT (2001) Interaction of cationic partial dendrimers with charged and neutral liposomes. International Journal of Pharmaceutics 214: 71-76.
29. Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, et al. (2004) Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: Hole formation and the relation to transport. Bioconjugate Chemistry 15: 774-782.
30. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, et al. (2006) Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chemistry 17: 728-734.
31. Mecke A, Uppuluri S, Sassanella TM, Lee DK, Ramamoorthy A, et al. (2004) Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chemistry and Physics of Lipids 132: 3-14.
32. Mecke A, Lee DK, Ramamoorthy A, Orr BG, Holl MMB (2005) Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers. Langmuir 21: 8588-8590.
33. Mecke A, Majoros IJ, Patri AK, Baker Jr JR, Banaszak Holl MM, et al. (2005) Lipid bilayer disruption by polycationic polymers: The roles of size and chemical functional group. Langmuir 21: 10348-10354.
34. Klajnert B, Epand RM (2005) PAMAM dendrimers and model membranes: Differential scanning calorimetry studies. International Journal of Pharmaceutics 305: 154-166.
35. Klajnert B, Janiszewska J, Urbanczyk-Lipkowska Z, Bryszewska M, Epand RM (2006) DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes. International Journal of Pharmaceutics 327: 145-152.
36. Gardikis K, Hatziantoniou S, Viras K, Wagner M, Demetzos C (2006) A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. International Journal of Pharmaceutics 318: 118-123.
37. Ionov M, Garaiova Z, Wróbel D, Waczulikova I, Gomez-Ramirez R, et al. (2011) The carbosilane dendrimers affect the size and zeta potential of large unilamellar vesicles. Acta Phys Univ Comenianae 52: 33-39.
38. Wrobel D, Kłys A, Ionov M, Vitovic P, Waczulikowa I, et al. (2012) Cationic carbosilane dendrimers-lipid membrane interactions. Chemistry and Physics of Lipids 165: 401-407.
39. Lee H, Larson RG (2008) Coarse-grained molecular dynamics studies of the concentration and size dependence of fifth- and seventh-generation PAMAM dendrimers on pore formation in DMPC bilayer. Journal of Physical Chemistry B 112: 7778-7784.
40. Smith PES, Brender JR, Dürr UHN, Xu J, Mullen DG, et al. (2010) Solid-state NMR reveals the hydrophobic-core location of poly(amidoamine) dendrimers in biomembranes. Journal of the American Chemical Society 132: 8087-8097.
41. Kelly CV, Liroff MG, Triplett LD, Leroueil PR, Mullen DG, et al. (2009) Stoichiometry and structure of poly(amidoamine) dendrimer- Lipid complexes. ACS Nano 3: 1886-1896.
42. Tiriveedhi V, Kitchens KM, Nevels KJ, Ghandehari H, Butko P (2011) Kinetic analysis of the interaction between poly(amidoamine) dendrimers and model lipid membranes. Biochimica et Biophysica Acta - Biomembranes 1808: 209-218.
43. Ottaviani MF, Matteini P, Brustolon M, Turro NJ, Jockusch S, et al. (1998) Characterization of starburst dendrimers and vesicle solutions and their interactions by CW- and pulsed-EPR, TEM, and dynamic light scattering. Journal of Physical Chemistry B 102: 6029-6039.
44. Ottaviani MF, Daddi R, Brustolon M, Turro NJ, Tomalia DA (1999) Structural modifications of DMPC vesicles upon interaction with poly(amidoamine) dendrimers studied by CW-electron paramagnetic resonance and electron spin-echo techniques. Langmuir 15: 1973-1980.
45. Wrobel D, Ionov M, Gardikis K, Demetzos C, Majoral JP, et al. (2011) Interactions of phosphorus-containing dendrimers with liposomes. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1811: 221-226.
46. Schwarz G, Stankowski S, Rizzo V (1986) Thermodynamic analysis of incorporation and aggregation in a membrane: application to the pore-forming peptide alamethicin. Biochim Biophys Acta 861: 141-151.
47. Eftink MR, Ghiron CA (1976) Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. Biochemistry 15: 672-680.
48. Yau WM, Wimley WC, Gawrisch K, White SH (1998) The preference of tryptophan for membrane interfaces. Biochemistry 37: 14713-14718.
49. Shai Y, Bach D, Yanovsky A (1990) Channel formation properties of synthetic pardaxin and analogues. J Biol Chem 265: 20202-20209.
50. Mozsolits H, Wirth HJ, Werkmeister J, Aguilar MI (2001) Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance. Biochim Biophys Acta 1512: 64-76.
51. Papo N, Shai Y (2003) Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry 42: 458-466.
52. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462: 55-70.
53. Seelig J (1997) Titration calorimetry of lipid-peptide interactions. Biochim Biophys Acta 1331: 103-116.
54. Cantor CR, Schimmel PR (1980) Biophysical chemistry: W. H. Freeman.
55. Andrushchenko VV, Aarabi MH, Nguyen LT, Prenner EJ, Vogel HJ (2008) Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial peptides with model and natural membranes. Biochim Biophys Acta 1778: 1004-1014.
56. Wenk MR, Seelig J (1998) Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. Biochemistry 37: 3909-3916.
57. Wieprecht T, Beyermann M, Seelig J (1999) Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure. Biochemistry 38: 10377-10387.
58. Klajnert B, Sadowska M, Bryszewska M (2004) The effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activity. Bioelectrochemistry 65: 23-26.
59. Klajnert B, Cortijo-Arellano M, Cladera J, Bryszewska M (2006) Influence of dendrimer's structure on its activity against amyloid fibril formation. Biochemical and Biophysical Research Communications 345: 21-28.
60. Smith DK (2008) Dendrimers and the double helix - From DNA binding towards gene therapy. Current Topics in Medicinal Chemistry 8: 1187-1203.
61. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications - Reflections on the field. Advanced Drug Delivery Reviews 57: 2106-2129.
62. Shcharbin D, Drapeza A, Loban V, Lisichenok A, Bryszewska M (2006) The breakdown of bilayer lipid membranes by dendrimers. Cell Mol Biol Lett 11: 242-248.
63. Lee H, Larson RG (2006) Molecular dynamics simulations of PAMAM dendrimer-induced pore formation in DPPC bilayers with a coarse-grained model. Journal of Physical Chemistry B 110: 18204-18211.
64. Yan LT, Yu X (2009) Enhanced permeability of charged dendrimers across tense lipid bilayer membranes. ACS Nano 3: 2171-2176.
65. Kelly CV, Leroueil PR, Orr BG, Holl MMB, Andricioaei L (2008) Poly(amidoamine) dendrimers on lipid bilayers II: Effects of bilayer phase and dendrimer termination. Journal of Physical Chemistry B 112: 9346-9353.
66. Leroueil PR, Hong S, Mecke A, Baker JR, Jr., Orr BG, et al. (2007) Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res 40: 335-342.
67. Hong S, Rattan R, Majoros IJ, Mullen DG, Peters JL, et al. (2009) The role of ganglioside GM1 in cellular internalization mechanisms of poly(amidoamine) dendrimers. Bioconjug Chem 20: 1503-1513.
68. Jain K, Kesharwani P, Gupta U, Jain NK (2010) Dendrimer toxicity: Let's meet the challenge. Int J Pharm 394: 122-142.
69. Guarnieri D, Falanga A, Muscetti O, Tarallo R, Fusco S, et al. (2013) Shuttle-mediated nanoparticle delivery to the blood-brain barrier. Small 9: 853-862.
70. Smaldone G, Falanga A, Capasso D, Guarnieri D, Correale S, et al. (2013) gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins. Int J Nanomedicine 8: 2555-2565.
71. Wimley WC, Hristova K (2011) Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol 239: 27-34.